Pharmadrug (Pharmadrug) Other Net Income (Loss) : $-2.02 Mil (TTM As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharmadrug Other Net Income (Loss)?

Pharmadrug's Other Net Income (Loss) for the three months ended in Sep. 2023 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.02 Mil.

Pharmadrug's annual Other Net Income (Loss) declined from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($-1.44 Mil) and declined from Dec. 2021 ($-1.44 Mil) to Dec. 2022 ($-4.28 Mil).

Pharmadrug Other Net Income (Loss) Historical Data

The historical data trend for Pharmadrug's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmadrug Other Net Income (Loss) Chart

Pharmadrug Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Net Income (Loss)

Get a 7-Day Free Trial

-0.28

-1.44

-4.28

Pharmadrug Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Net Income (Loss)	Get a 7-Day Free Trial															1.54	-2.02	-	-	-

Pharmadrug Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.02 Mil.

Pharmadrug Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Pharmadrug's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmadrug (Pharmadrug) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmadrug Inc (OTCPK:LMLLF) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

G11:Germany PHRX:Canada

Address

77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1

Website

https://www.pharmadrug.ca

Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.